Results 21 to 30 of about 774,787 (241)
Otolaryngology Case Reports, 2022 Introduction: Angiotensin converting enzyme (ACE) inhibitors are a leading class of antihypertensives, which are a well-documented cause of angioedema related to prescription drugs. The purpose of this report is to highlight the importance of recognition
Christopher Wojcik, Brian Farrell
doaj +1 more source
The use of angiotensin-converting enzyme inhibitors in general medicine
South African Family Practice, 2012 Angiotensin-converting enzyme (ACE) inhibitors are a class of drugs commonly used in the management of hypertension, congestive heart failure, cerebrovascular disease, stable coronary heart disease and diabetes-associated nephropathy.
M.L.I. Mashitisho
doaj +1 more source
PLoS ONE, 2021 IntroductionThis meta-analysis aimed to summarize the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients.MethodsRandomized ...
Jia Yao +5 more
doaj +1 more source
ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?
Рациональная фармакотерапия в кардиологии, 2016 New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known.
D. V. Nebieridze, A. S. Safarian
doaj +1 more source
Kidney & Blood Pressure Research, 2018 Background/Aims: Whether angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB) could benefit patients with diabetes and albuminuria remains controversial.
Kanran Wang +7 more
doaj +1 more source
Ace inhibitors and cardiac remodeling in congestive heart failure
, 2021 The thesis explains in detail the pathophysiology of heart failure and the role of Ace inhibitors in slowing the progression of heart failure by directly and indirectly slowing cardiac myocytes remodeling and ventricular hypertrophyáltalános ...
Abu Ghazaleh, Mohammad
core
, 2023 <p>Discover the profound impact of the project through our comprehensive EGI-ACE Impact Report, showcasing the Key Exploitable Results, Success stories and Impacts on different areas.</p ...
EGI-ACE Consortium
core +1 more source
Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes [PDF]
, 1994 Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Anaphylactoid reactions (AR) are the most feared complications of hemodialysis.
Verresen, Luc +7 more
core +1 more source
A genome-wide search replicates evidence of a quantitative trait locus for circulating angiotensisn l-converting enzyme (ACE) unlinked to the ACE gene [PDF]
, 2008 Background: angiotensin I-converting enzyme (ACE) plays an important role in cardiovascular homeostasis. There is evidence from different ethnic groups that circulating ACE levels are influenced by a quantitative trait locus (QTL) at the ACE gene on ...
Amy Luke +20 more
core +2 more sources
International Journal of Pharmacy & Integrated Health SciencesBackground: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam +6 more
doaj +1 more source